Dow Down 0.92% Nasdaq Down 0.83%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
31.40 0.73(2.27%) Oct 22, 4:00PM EDT
Prev Close:32.13
Open:32.27
Bid:27.50 x 100
Ask:36.10 x 2000
1y Target Est:60.60
Beta:-0.22
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:31.16 - 32.70
52wk Range:26.25 - 101.00
Volume:520,018
Avg Vol (3m):1,077,520
Market Cap:927.78M
P/E (ttm):N/A
EPS (ttm):-1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRDown 2.27%927.78M
AZN86.87B
MRK160.13B
PFE179.45B

Key Statistics

Forward P/E (1 yr):19.62
P/S (ttm):9.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.87
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback